Anti-Müllerian hormone may regulate the number of calbindin-positive neurons in the sexually dimorphic nucleus of the preoptic area of male mice
© Wittmann and McLennan; licensee BioMed Central Ltd. 2013
Received: 24 May 2013
Accepted: 2 October 2013
Published: 11 October 2013
The male brain is putatively organised early in development by testosterone, with the sexually dimorphic nucleus of the medial preoptic area (SDN) a main exemplifier of this. However, pubescent neurogenesis occurs in the rat SDN, and the immature testes secrete anti-Müllerian hormone (AMH) as well as testosterone. We have therefore re-examined the development of the murine SDN to determine whether it is influenced by AMH and/or whether the number of calbindin-positive (calbindin+ve) neurons in it changes after pre-pubescent development.
In mice, the SDN nucleus is defined by calbindin+ve neurons (CALB-SDN). The number and size of the neurons in the CALB-SDN of male and female AMH null mutant (Amh -/- ) mice and their wild-type littermates (Amh +/+ ) were studied using stereological techniques. Groups of mice were examined immediately before the onset of puberty (20 days postnatal) and at adulthood (129–147 days old).
The wild-type pre-pubertal male mice had 47% more calbindin+ve neurons in the CALB-SDN than their female wild-type littermates. This sex difference was entirely absent in Amh -/- mice. In adults, the extent of sexual dimorphism almost doubled due to a net reduction in the number and size of calbindin+ve neurons in females and a net increase in neuron number in males. These changes occurred to a similar extent in the Amh -/- and Amh +/+ mice. Consequently, the number of calbindin+ve neurons in Amh -/- adult male mice was intermediate between Amh +/+ males and Amh +/+ females. The sex difference in the size of the neurons was predominantly generated by a female-specific atrophy after 20 days, independent of AMH.
The establishment of dimorphic cell number in the CALB-SDN of mice is biphasic, with each phase being subject to different regulation. The second phase of dimorphism is not dependent on the first phase having occurred as it was present in the Amh -/- male mice that have female-like numbers of calbindin+ve neurons at 20 days. These observations extend emerging evidence that the organisation of highly dimorphic neuronal networks changes during puberty or afterwards. They also raise the possibility that cellular events attributed to the imprinting effects of testosterone are mediated by AMH.
KeywordsSexual dimorphic nucleus Anti-Müllerian hormone Puberty Development Childhood Calbindin Medial preoptic area Imprinting
The sexually dimorphic structures in the brain are generally considered to form early in development, with the role of pubescent hormones limited to activation and refinement of existing neuronal networks [1–3]. However, this concept dates from an era when remodelling of the postnatal brain was thought impossible. Consequently, most historic experiments relating to the control of neuron number have endpoints before puberty and would therefore not detect a pubescent change in cell number. Pubescent neurogenesis  and pubescent loss of cortical neurons  have recently been reported in rodents, creating a rationale to reassess when cell number is established in the highly dimorphic brain nuclei. We report here that the number of calbindin-positive (calbindin+ve) neurons in the sexually dimorphic nucleus of the medial preoptic area (CALB-SDN) of mice is dimorphic before puberty but with the extent of dimorphism subsequently doubling during or after puberty.
The immature testes produce anti-Müllerian hormone (AMH, also known as MIS) as well as testosterone. The role of AMH as a regulator of sexual differentiation is also changing. Historically, it was thought to have a single function, to initiate the regression of the uterus in male embryos . However, AMH and its unique type 2 receptor are highly conserved genes and predate the evolution of the uterus . In some teleost species (a class of ray-finned fish), AMH appears to determine sex [7, 8]. These observations raise the possibility that AMH has a broader role in virilisation than previously suspected.
Contemporary studies of mice point to the brain as a site of gonadal AMH action. The immature testes of humans, rodents and other mammals continuously secrete high levels of AMH during embryonic and postnatal development until puberty, at which stage AMH levels in males decline rapidly. In men and adult male mice, plasma AMH levels are typically less than 5% of the levels during development [6, 9–11]. Ovarian production of AMH, in contrast, begins as females enter puberty, with the consequence that young male and female adults have similar levels of AMH [11–13]. The AMH in blood is entirely derived from the gonads [10, 14]. AMH receptors are ubiquitously expressed in developing murine neurons , with AMH being required for the male exploratory behaviour [14, 15] and the male bias in the number of cerebellar Purkinje and spinal motor neurons [14, 16, 17]. The spinal bulbocavernosus neurons, in contrast, develop independently of AMH . We report here that the initial sexual dimorphism in the number of neurons in the CALB-SDN is absent in Amh -/- mice.
C57BL/6 Amh-/- and Amh+/+ mice were littermates generated from Amh+/- parents [18, 19] (The Jackson Laboratory, Bar Harbor, ME, USA) and were housed as previously described . The Animal Ethics Committee of the University of Otago approved all experiments.
Age-matched pre-pubertal (20 days old) and adult (129–147 days old) mice of both sexes were used in this study, with the adult female mice collected at a random stage of the estrous cycle. Six mice were analysed for each group. The mice were anaesthetized with ketamine (225 mg/kg) and Domitor (3 mg/kg) and transcardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4, using a peristaltic pump (adults, 13.3 ml/min; 20 days, 10.0 ml/min) over 3 min. The brains were incubated in the same fixative for 2 h at room temperature (RT), followed by 36 h in 4% paraformaldehyde containing 15% sucrose at 4°C and then overnight at 4°C in 30% sucrose in 0.01 M PB, pH 7.4. They were then embedded in Tissue-Tek (Sakura Finetek USA, Torrance, CA, USA), frozen on dry ice and stored at -80°C. A notch was made in the cortex of the right-hand side to enable a consistent side of the brain to be studied.
The brain region containing the CALB-SDN was serially sectioned at a thickness of 20 μm in a cryostat, and every third section was immediately stained with an anti-calbindin antibody (C9848, Sigma Aldrich, St. Louis, MO, USA). The sections were stained by free-floating immunohistochemistry. Each section was incubated in a 30 mM sodium citrate buffer, pH 8.7, for 10 min at 80°C using a water bath to heat the incubation chamber. The sections were then cooled at RT for 20 min, washed twice with 0.1 M glycine in PB (0.01 M PB, pH 7.2) for 5 min and then blocked in 5% donkey serum (Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at RT. The sections were then incubated in 1.85 μg/ml of mouse monoclonal anti-calbindin-D28k for 18 h at 4°C with gentle vibration. Other sections were incubated in control IgG. The sections were washed six times in washing buffer (0.01 M PB, pH 7.2, 2% NaCl, 0.1% Tween-20) for 5 min, incubated in 2 μg/ml of biotinylated donkey anti-mouse IgG (Jackson ImmunoResearch) for 1.5 h at RT and washed three times for 5 min, followed by an incubation in 1% H2O2 for 10 min to inactivate endogenous peroxidases. Sections were then washed three times in PB for 5 min, incubated with biotin/peroxidase-conjugated streptavidin amplification complex (1:200, Amersham Biosciences/GE Healthcare Ltd, Auckland, New Zealand) for 1.5 h at RT, washed three times in PB for 5 min and once in 0.1 M acetate buffer, pH 5.2, for 5 min, stained with AEC (3-amino-9-ethylcarbazole, Sigma-Aldrich) substrate for 12 min and mounted on gelatine-coated microscopy slides.
The number of calbindin+ve neurons in both hemispheres of each mouse was estimated using the principles of the fractionator method . The entire CALB-SDN was examined on each section with a 0.75 numerical aperture lens on a light microscope (Zeiss Axioplan, Oberkochen, Germany). To ensure that all calbindin+ve neurons in the CALB-SDN were examined and to avoid double counting errors, the position of each calbindin+ve neuron was traced using a camera lucida. Calbindin+ve cells were excluded from data collection when the perikaryon was cut at the upper plane and included when intact or cut at the lower plane of the sections. Every third consecutive section was used for calbindin staining and cell counting. The total number of calbindin+ve neurons in the CALB-SDN was estimated by multiplying the number of cells counted by three.
The sizes of the perikaryon of the calbindin+ve neurons were measured using the direct moment estimation of the volume of particles, which allows the unbiased estimation of volume from single sections. The diameters of neurons were measured in a random direction through a random test-point with a 0.75 numerical aperture lens using the camera lucida on a light microscope (Zeiss Axioplan). The volumes were calculated with the estimator π/3 times the diameter length l 0 raised to the third power . Approximately 20 cells per hemisphere of each animal were used for the volumetric analysis and the mean size calculated for each mouse.
The microscope slides were coded to blind the observer (WW) to the sex and genotype of the mice. All presented data are from the left hemisphere as no differences were detected between the left and right hemispheres.
Statistical calculations were undertaken with either PASWstatistics18.0 (SPSS Inc, IBM, Armonk, NY, USA) or GraphPad Prism software (http://www.graphpad.com). Data were examined by two-way analysis of variance (ANOVA) for (1) sex and genotype differences and (2) age and genotype differences. Significant effects were confirmed by Student’s t test, with p values of <0.05 recorded in the figures and tables.
The CALB-SDN underwent multiple changes between 20 days and adulthood. The number of calbindin+ve neurons increased slightly in the Amh +/+ male mice (Figure 3B,C) and significantly decreased in the Amh +/+ female mice (Figure 3B,C). This caused the mean male-to-female ratio of neurons to increase from 1.47 (20 days) to 2.62 (adult). The male increase and female decrease in the number of calbindin+ve neurons occurred in both the Amh +/+ and Amh -/- mice (Figure 3C). Consequently, the proportion of dimorphism that is attributable to AMH decreased from approximately 100% at 20 days to 59% in the adult. In a two-way ANOVA test, the number of calbindin+ve neurons were significantly different, with respect to sex (p < 0.001) and genotype (p = 0.002), with a significant sex × genotype interaction (p = 0.003).
The size of the neuronal soma also became dimorphic after 20 days of age, due to a slight hypertrophy in the males and a slightly larger atrophy in the females (Figure 4). The overall sex difference in the size of the calbindin+ve neurons was, however, only 7%. As with neuronal number, the change in the size of the neuronal soma was similar in the Amh +/+ and Amh -/- mice (Figure 4C).
The appearance of the calbindin+ve neurons also became dimorphic after 20 days, with the intensity of the calbindin+ve immunoreactivity being consistently stronger in the male than in the female mice (Figure 2). This was not due to variation in the immunohistochemical procedure as the brains were processed in groups of four, each of which contained one female and one male brain of each genotype. This difference was independent of the Amh genotype of the mice.
The control of the number of the calbindin+ve neurons in the murine CALB-SDN is biphasic, with both a pre-pubertal phase and a phase that occurs after 20 days. These two phases appear to involve different sex-specific inducers, with the second phase involving changes in both female and male mice.
In female mice, the number of calbindin+ve neurons in the CALB-SDN decreased between 20 days and adulthood, indicating that some of the neurons in the pre-pubescent form of the nucleus either degenerated or differentiated into another cell type. This is consistent with archival descriptions of the SDN of the medial preoptic area in rats (herein referred to as SDN), which showed a decrease in the total volume of the nucleus in females between day 10 and adulthood . A female-specific loss of neurons occurs during puberty in the rat prefrontal cortex , raising the possibility that pubescent loss of neurons may be a broad feature of female brain development. If so, then this would partially explain why the average size of the human female brain decreases by over 10% during puberty .
The direction of pubescent change in the male CALB-SDN was opposite to that in the females, with the number of calbindin+ve neurons increasing after 20 days. This is consistent with the recent study of Ahmed et al. demonstrating the existence of gonadal-dependent neurogenesis during puberty . The magnitude of this increase was similar in the Amh +/+ and Amh -/- mice, indicating that the pubescent increase in the size of the male CALB-SDN is independent of the pre-pubescent virilisation of the nucleus by AMH (see below). This notwithstanding, the number of calbindin+ve neurons in the CALB-SDN of adult male Amh -/- mice was still less than that of the Amh +/+ males, due to the different pre-pubescent development of the Amh -/- and Amh +/+ mice. The functional significance of this will depend on whether the AMH-dependent and AMH-independent neurons in the CALB-SDN have similar or distinct roles.
The current study was not designed to examine the mechanism of the pubescent changes, only to detect whether a change occurs after 20 days. The data presented represent net changes. Consequently, neuronal loss, neurogenesis and/or change in cell type may be occurring in both sexes, with a female bias to the reduction in calbindin+ve neurons and a male bias to the increase in calbindin+ve neurons. It is also possible that some neurons change from a calbindin+ve to a calbindin-ve phenotype (or vice versa), although this is unlikely to be a complete explanation for the current data (Figures 3 and 4), given the rat observations noted above [4, 24].
Pre-pubertal ('childhood’) dimorphism and testosterone imprinting
High dimorphic levels of testosterone are only transiently present during development, with many features of the male brain being induced during this period. Some of the effects of testosterone during this period are mediated by the androgen receptor, whereas other effects are mediated by oestrogen receptors, after local aromatisation of testosterone . The male features which develop between the perinatal and pubescent surges of testosterone are putatively generated by the prior exposure to testosterone. We refer to this as testosterone imprinting. As detailed below, the SDN of rats and the CALB-SDN in mice are exemplifiers of imprinting through the actions of aromatised testosterone. The dimorphism present in the CALB-SDN immediately before the onset of puberty (20 days) was absent in the Amh -/- mice, indicating that most or all of this initial dimorphism is dependent on AMH. The blood levels of testosterone in Amh -/- male mice are therefore of interest.
AMH is a natural repressor of Leydig cell formation  and a putative inhibitor of testosterone production , with pathological elevation of AMH levels leading to feminisation of mice, due to an apparent insufficiency of testosterone . Conversely, Amh-/- mice have an extensive Leydig cell hyperplasia [29, 30], which, in isolation of other factors, should lead to increased levels of testosterone and increased sexual dimorphism. However, AMH also appears to negatively regulate the maturation of Leydig cells , with the results that testosterone levels in Amh -/- male mice are within the normal male range [17, 30, 31], although data is not currently available for either foetal or neonatal mice. The potency of a hormone in vivo is regulated by binding proteins and other influences, with a biological readout of a hormone being particularly important for this reason. The male features of Amh-/- mice that develop during either the foetal/neonatal or the pubertal surges of testosterone are quantitatively normal [17, 29]. Hence, in our view, the complete absence of dimorphism in calbindin cell number in the 20-day-old mice is unlikely to be due to insufficient testosterone levels. This raises the possibility that AMH and the sex steroids dually regulate the CALB-SDN neurons (but see below). If so, then both AMH and testosterone may be needed to produce a male bias in the number of calbindin+ve neurons.
Testosterone regulation of the neonatal SDN is postulated to involve local aromatisation of androgens to oestrogens [21, 32, 33]. Consequently, the putative actions of testosterone on this nucleus will be dependent on the expression of aromatase in the CALB-SDN as well as the plasma levels of testosterone. In this context, it will be important to determine whether the male bias in the expression of aromatase in the brain  is AMH dependent. If so, then feminisation of the CALB-SDN in the Amh -/- male pups could be secondary to diminished conversion of testosterone to oestrogen.
Alternatively, the current results can be viewed as a challenge to the concept of testosterone imprinting. The non-dimorphic development of neurons are controlled by multiple factors, each of which acts at a particular stage of cell development (e.g. migration of the neuron, initial axon outgrowth, dendritic branching, etc.). All of these factors promote the survival of the neuron during development, but only the target-derived factor controls the number of neurons in the nucleus. When physiological regulators of neurons are injected at times when they are not normally present, then they mimic the action of the endogenous (natural) regulator. Consequently, if the physiological regulator of developmental cell death is added when the neuron is extending an axon, the regulator will promote axon outgrowth; conversely, if the physiological regulator of axon outgrowth is added during the period of cell death, then it will promote neuronal survival (see  for a discussion of this). For this reason, proof that a regulator is present at the time a cellular event is occurring is one of the most important criteria to prove the function of a non-dimorphic regulator of the brain (neurotrophic theory [35, 36]).
The initial sex difference in the number of SDN neurons is created by a female bias in the extent of neuronal cell death [37, 38]. The cell death in the SDN occurs after the neonatal surge of testosterone, during the period when the plasma levels of AMH but not testosterone are highly dimorphic (cf. [21, 37] and [11, 39]). The low adult ovarian production of AMH  is only beginning during this period . The homologous nucleus in humans also develops when boys have high levels of AMH and only female-like levels of testosterone (cf.  and [9, 42]). Hence, if neurotrophic theory is applicable, then this pattern of hormone secretion is consistent with AMH regulating the number of calbindin+ve neurons of the CALB-SDN and is inconsistent with testosterone having this action.
All cytokine regulators of developing neurons leave a lasting imprint on neuronal networks, yet testosterone is the only regulator that is postulated to control neuronal development through an imprinting mechanism. The concept of testosterone imprinting was developed before the existence of gonadal protein hormones was known, when imprinting was the only apparent possibility for explaining the importance of the gonads. The proof of imprinting is predominantly based on experiments involving castration and the injection of non-physiological levels of the sex steroids into female mice. Castration removes testosterone, but it also removes AMH and other gonadal protein hormones (e.g. the inhibins [43–46]) that have dimorphic aspects to their secretion. Experiments based on castration are therefore open to multiple interpretations. Experiments involving the administration of the sex steroids are similarly open to debate for two reasons. First, the steroids have typically been used at high concentrations, without proof that the induced levels mirror the natural levels of testosterone in developing males. Of particular concern is whether steroids injected during the neonatal period persist into the subsequent days when developing males only have low levels of testosterone . Second, both the testes and the ovaries produce the same protein hormones, but in different amounts and at different times in the life cycle. AMH, for example, is the most dimorphic of all the gonadal hormones during development, but is only minimally dimorphic in young adults [6, 9–11]. Oestrogen and testosterone are paracrine regulators of the ovary , with oestrogen being a putative regulator of AMH production by ovarian granulosa cells . The effect of non-physiological administration of the sex steroids on the secretion of protein hormones from the immature ovary (and testes) is largely unknown. In the absence of this information, any experiment involving a manipulation of one gonadal hormone has a degree of uncertainty because the effect on other hormones has not been fully characterised. This uncertainty extends in part to the current data. Hence, in our view, the concept of testosterone imprinting is not yet robustly proven.
This alternative view does not argue against the importance of the sex steroids. It simply suggests that the criteria used to identify the non-dimorphic regulators of the brain [35, 36] are applicable to the study of the dimorphic regulators of the brain. If so, the available evidence points to testosterone regulating cellular events in the CALB-SDN before and after the AMH-mediated regulation of cell number. Non-dimorphic regulators of the brain have different actions on different types of neurons. Hence, the argument that AMH generates the male bias in neuron number in the CALB-SDN (this manuscript) and other neurons [14, 17, 49] is not an argument against testosterone having a similar action on neurons in populations where the control of cell number occurs during either the perinatal or the pubescent surges of testosterone.
The control of neuron number in the CALB-SDN appears to be biphasic, with the different phases subject to different regulation. One interpretation of this data is that organisation and activation events occur early in development and during puberty, with the testicular influence being continuous through direct non-imprinting effects of protein and steroid hormones, acting at different times.
This study was supported by the Marsden Fund (The Royal Society of New Zealand). The authors thank N. Batchelor for the production and care of the mice.
- Morris JA, Jordan CL, Breedlove SM: Sexual differentiation of the vertebrate nervous system. Nat Neurosci 2004, 7: 1034–1039. 10.1038/nn1325PubMedView ArticleGoogle Scholar
- Schwarz JM, McCarthy MM: Steroid-induced sexual differentiation of the developing brain: multiple pathways, one goal. J Neurochem 2008, 105: 1561–1572. 10.1111/j.1471-4159.2008.05384.xPubMed CentralPubMedView ArticleGoogle Scholar
- Collaer ML, Hines M: Human behavioral sex differences: a role for gonadal hormones during early development? Psychol Bull 1995, 118: 55–107.PubMedView ArticleGoogle Scholar
- Ahmed EI, Zehr JL, Schulz KM, Lorenz BH, Doncarlos LL, Sisk CL: Pubertal hormones modulate the addition of new cells to sexually dimorphic brain regions. Nat Neurosci 2008, 11: 995–997. 10.1038/nn.2178PubMed CentralPubMedView ArticleGoogle Scholar
- Markham JA, Morris JR, Juraska JM: Neuron number decreases in the rat ventral, but not dorsal, medial prefrontal cortex between adolescence and adulthood. Neuroscience 2007, 144: 961–968. 10.1016/j.neuroscience.2006.10.015PubMedView ArticleGoogle Scholar
- MacLaughlin DT, Donahoe PK: Sex determination and differentiation. New Eng J Med 2004, 350: 367–378. 10.1056/NEJMra022784PubMedView ArticleGoogle Scholar
- Morinaga C, Saito D, Nakamura S, Sasaki T, Asakawa S, Shimizu N, Mitani H, Furutani-Seiki M, Tanaka M, Kondoh H: The hotei mutation of medaka in the anti-Müllerian hormone receptor causes the dysregulation of germ cell and sexual development. Proc Natl Acad Sci U S A 2007, 104: 9691–9696. 10.1073/pnas.0611379104PubMed CentralPubMedView ArticleGoogle Scholar
- Hattori RS, Murai Y, Oura M, Masuda S, Majhi SK, Sakamoto T, Fernandino JI, Somoza GM, Yokota M, Strussmann CA: A Y-linked anti-Müllerian hormone duplication takes over a critical role in sex determination. Proc Natl Acad Sci U S A 2012, 109: 2955–2959. 10.1073/pnas.1018392109PubMed CentralPubMedView ArticleGoogle Scholar
- Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT: Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996, 81: 571–576. 10.1210/jc.81.2.571PubMedGoogle Scholar
- Aksglaede L, Sørensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, Skakkebæk NE, Juul A: Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010, 95: 5357–5364. 10.1210/jc.2010-1207PubMedView ArticleGoogle Scholar
- Al-Attar L, Noel K, Dutertre M, Belville C, Forest MG, Burgoyne PS, Josso N, Rey R: Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J Clin Invest 1997, 100: 1335–1343. 10.1172/JCI119653PubMed CentralPubMedView ArticleGoogle Scholar
- Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT, Petersen JH, Linneberg A, Kjaergaard S, Juul A: Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010, 95: 5003–5010. 10.1210/jc.2010-0930PubMedView ArticleGoogle Scholar
- Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born BM, de Jong FH, Groome NP, Themmen AP, Visser JA: Serum anti-Müllerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006, 147: 3228–3234. 10.1210/en.2005-1588PubMedView ArticleGoogle Scholar
- Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K, McLennan IS: Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci U S A 2009, 106: 7203–7208. 10.1073/pnas.0902253106PubMed CentralPubMedView ArticleGoogle Scholar
- Morgan K, Meredith J, Kuo J-YA, Bilkey DK, McLennan IS: The sex bias in novelty preference of preadolescent mouse pups may require testicular Müllerian inhibiting substance. Behav Brain Res 2011, 221: 304–306. 10.1016/j.bbr.2011.02.048PubMedView ArticleGoogle Scholar
- Wang PY, Koishi K, McGeachie AB, Kimber M, Maclaughlin DT, Donahoe PK, McLennan IS: Mullerian inhibiting substance acts as a motor neuron survival factor in vitro . Proc Natl Acad Sci U S A 2005, 102: 16421–16425. 10.1073/pnas.0508304102PubMed CentralPubMedView ArticleGoogle Scholar
- Wittmann W, McLennan IS: The male bias in the number of Purkinje cells and the size of the murine cerebellum may require Müllerian inhibiting substance/anti-Müllerian hormone. J Neuroendocrinol 2011, 23: 831–838. 10.1111/j.1365-2826.2011.02187.xPubMedView ArticleGoogle Scholar
- Behringer RR, Finegold MJ, Cate RL: Müllerian-inhibiting substance function during mammalian sexual development. Cell 1994, 79: 415–425. 10.1016/0092-8674(94)90251-8PubMedView ArticleGoogle Scholar
- Wang J, Dicken C, Lustbader JW, Tortoriello DV: Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometrium. Fertil Steril 2009, 91: 1195–1203. 10.1016/j.fertnstert.2008.01.028PubMedView ArticleGoogle Scholar
- McLennan IS, Taylor-Jeffs J: The use of sodium lamps to brightly illuminate mouse houses during their dark phases. Lab Anim 2004, 38: 1–9.View ArticleGoogle Scholar
- Sickel MJ, McCarthy MM: Calbindin-D28k immunoreactivity is a marker for a subdivision of the sexually dimorphic nucleus of the preoptic area of the rat: developmental profile and gonadal steroid modulation. J Neuroendocrinol 2000, 12: 397–402.PubMedView ArticleGoogle Scholar
- Paxinos G, Franklin KBJ: The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic; 2003.Google Scholar
- Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, West MJ: The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Acta Pathol Microbiol Immunol Scand 1988, 96: 857–881.View ArticleGoogle Scholar
- Jacobson CD, Shryne JE, Shapiro F, Gorski RA: Ontogeny of the sexually dimorphic nucleus of the preoptic area. J Comp Neurol 1980, 193: 541–548. 10.1002/cne.901930215PubMedView ArticleGoogle Scholar
- Giedd JN, Rapoport JL: Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron 2010, 67: 728–734. 10.1016/j.neuron.2010.08.040PubMed CentralPubMedView ArticleGoogle Scholar
- Mendis-Handagama SM, Ariyaratne HB, Fecteau KA, Grizzle JM, Jayasundera NK: Comparison of testis structure, function and thyroid hormone levels in control C57BL/6 mice and anti-Mullerian hormone over expressing mice. Histol Histopathol 2010, 25: 901–908.PubMedGoogle Scholar
- Sriraman V, Niu E, Matias JR, Donahoe PK, MacLaughlin DT, Hardy MP, Lee MM: Müllerian inhibiting substance inhibits testosterone synthesis in adult rats. J Androl 2001, 22: 750–758.PubMedGoogle Scholar
- Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL: Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance. Nature 1990, 345: 167–170. 10.1038/345167a0PubMedView ArticleGoogle Scholar
- Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR: Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 1996, 10: 2577–2587. 10.1101/gad.10.20.2577PubMedView ArticleGoogle Scholar
- Wu X, Arumugam R, Baker SP, Lee MM: Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice. Endocrinology 2005, 146: 589–595.PubMedView ArticleGoogle Scholar
- Racine C, Rey R, Forest MG, Louis F, Ferre A, Huhtaniemi I, Josso N, di Clemente N: Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci U S A 1998, 95: 594–599. 10.1073/pnas.95.2.594PubMed CentralPubMedView ArticleGoogle Scholar
- Dohler KD, Coquelin A, Davis F, Hines M, Shryne JE, Gorski RA: Differentiation of the sexually dimorphic nucleus in the preoptic area of the rat brain is determined by the perinatal hormone environment. Neurosci Lett 1982, 33: 295–298. 10.1016/0304-3940(82)90388-3PubMedView ArticleGoogle Scholar
- Gilmore RF, Varnum MM, Forger NG: Effects of blocking developmental cell death on sexually dimorphic calbindin cell groups in the preoptic area and bed nucleus of the stria terminalis. Biol Sex Differ 2012, 3: 5. 10.1186/2042-6410-3-5PubMed CentralPubMedView ArticleGoogle Scholar
- Lephart ED, Lund TD, Horvath TL: Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function. Brain Res Brain Res Rev 2001, 37: 25–37. 10.1016/S0165-0173(01)00111-4PubMedView ArticleGoogle Scholar
- Glebova NO, Ginty DD: Growth and survival signals controlling sympathetic nervous system development. Ann Rev Neurosci 2005, 28: 191–222. 10.1146/annurev.neuro.28.061604.135659PubMedView ArticleGoogle Scholar
- Oppenheim RW: Neurotrophic survival molecules for motoneurons: an embarrassment of riches. Neuron 1996, 17: 195–197. 10.1016/S0896-6273(00)80151-8PubMedView ArticleGoogle Scholar
- Davis EC, Popper P, Gorski RA: The role of apoptosis in sexual differentiation of the rat sexually dimorphic nucleus of the preoptic area. Brain Res 1996, 734: 10–18. 10.1016/0006-8993(96)00298-3PubMedView ArticleGoogle Scholar
- Dodson RE, Gorski RA: Testosterone propionate administration prevents the loss of neurons within the central part of the medial preoptic nucleus. J Neurobiol 1993, 24: 80–88. 10.1002/neu.480240107PubMedView ArticleGoogle Scholar
- Motelica-Heino I, Castanier M, Corbier P, Edwards DA, Roffi J: Testosterone levels in plasma and testes of neonatal mice. J Steroid Biochem 1988, 31: 283–286. 10.1016/0022-4731(88)90351-2PubMedView ArticleGoogle Scholar
- Durlinger AL, Visser JA, Themmen AP: Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002, 124: 601–609. 10.1530/rep.0.1240601PubMedView ArticleGoogle Scholar
- Swaab DF, Hofman MA: Sexual differentiation of the human hypothalamus: ontogeny of the sexually dimorphic nucleus of the preoptic area. Brain Res Dev Brain Res 1988, 44: 314–318. 10.1016/0165-3806(88)90231-3PubMedView ArticleGoogle Scholar
- Wudy SA, Wachter UA, Homoki J, Teller WM: 17 alpha-hydroxyprogesterone, 4-androstenedione, and testosterone profiled by routine stable isotope dilution/gas chromatography–mass spectrometry of children. Ped Res 1995, 38: 76–80. 10.1203/00006450-199507000-00013View ArticleGoogle Scholar
- Debieve F, Beerlandt S, Hubinont C, Thomas K: Gonadotropins, prolactin, inhibin A, inhibin B and activin A in human fetal serum from midpregnancy and term pregnancy. J Clin Endo Metab 2000, 85: 270–274. 10.1210/jc.85.1.270View ArticleGoogle Scholar
- Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, Kelnar CJ: Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage. FSH and testosterone. Clin Endocrinol (Oxf) 2002, 56: 215–221. 10.1046/j.0300-0664.2001.01448.xView ArticleGoogle Scholar
- Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, Kelnar CJ: Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, FSH and oestradiol. Clin Endocrinol 2002, 56: 223–230. 10.1046/j.0300-0664.2001.01449.xView ArticleGoogle Scholar
- Ackland JF, Schwartz NB: Changes in serum immunoreactive inhibin and follicle-stimulating hormone during gonadal development in male and female rats. Biol Reprod 1991, 45: 295–300. 10.1095/biolreprod45.2.295PubMedView ArticleGoogle Scholar
- Walters KA, Allan CM, Handelsman DJ: Androgen actions and the ovary. Biol Reprod 2008, 78: 380–389. 10.1095/biolreprod.107.064089PubMedView ArticleGoogle Scholar
- Grynberg M, Pierre A, Rey R, Leclerc A, Arouche N, Hesters L, Catteau-Jonard S, Frydman R, Picard JY, Fanchin R, Veitia R, di Clemente N, Taieb J: Differential regulation of ovarian anti-Müllerian hormone (AMH) by estradiol through alpha- and beta-estrogen receptors. J Clin Endocrinol Metab 2012, 97: E1649–1657. 10.1210/jc.2011-3133PubMedView ArticleGoogle Scholar
- Wittmann W, McLennan IS: The bed nucleus of the stria terminalis has developmental and adult forms in mice, with the male bias in the developmental form being dependent on testicular AMH. Horm Behav 2013. in pressGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.